Deutsche Bank
TERN

Deutsche Bank’s Terns Pharmaceuticals TERN Stock Holding History

Deutsche Bank’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.87M Sell
149,327
-252,119
-63% -$10.4M ﹤0.01% 1131
2025
Q4 		$16.2M Buy
401,446
+20,697
+5% +$478K 0.01% 932
2025
Q3 		$2.86M Buy
380,749
+7,502
+2% +$47.9K ﹤0.01% 1572
2025
Q2 		$1.39M Sell
373,247
-12,230
-3% -$38.2K ﹤0.01% 1909
2025
Q1 		$1.06M Sell
385,477
-12,902
-3% -$52.7K ﹤0.01% 2121
2024
Q4 		$2.21M Sell
398,379
-144,467
-27% -$978K ﹤0.01% 1786
2024
Q3 		$4.53M Buy
542,846
+445,668
+459% +$3.67M ﹤0.01% 1314
2024
Q2 		$662K Buy
97,178
+73,526
+311% +$445K ﹤0.01% 2203
2024
Q1 		$155K Buy
23,652
+664
+3% +$4.34K ﹤0.01% 2966
2023
Q4 		$149K Buy
22,988
+539
+2% +$2.85K ﹤0.01% 3026
2023
Q3 		$113K Buy
22,449
+4,121
+22% +$26.2K ﹤0.01% 3107
2023
Q2 		$160K Buy
+18,328
New +$214K ﹤0.01% 3020
2022
Q2 		– Sell
-8,033
Closed -$24K – 4320
2022
Q1 		$24K Sell
8,033
-878
-10% -$3.75K ﹤0.01% 4030
2021
Q4 		$63K Buy
8,911
+440
+5% +$3.66K ﹤0.01% 3887
2021
Q3 		$88K Buy
8,471
+2,577
+44% +$26.7K ﹤0.01% 3944
2021
Q2 		$72K Buy
5,894
+408
+7% +$6.95K ﹤0.01% 4234
2021
Q1 		$121K Buy
+5,486
New +$120K ﹤0.01% 3879

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Deutsche Bank's TERN Position: Q1 2026 in Review

Deutsche Bank reduced its Terns Pharmaceuticals (TERN) stake by 63% in Q1 2026, selling an estimated $10.4M and leaving 149,327 shares worth $7.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

Deutsche Bank first reported a position in TERN in Q1 2021 and has held it in 17 quarters since. The position peaked at $16.2M in Q4 2025. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Deutsche Bank held 149,327 shares of Terns Pharmaceuticals worth $7.87M as of Q1 2026.
  • Deutsche Bank sold 252,119 Terns Pharmaceuticals shares in Q1 2026, an estimated $10.4M.
  • Terns Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1131 holding.
  • Deutsche Bank first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 17 quarters since.
  • Deutsche Bank's Terns Pharmaceuticals position peaked at $16.2M in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.